Complement and systemic lupus erythematosus
Open Access
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 4 (Suppl 3) , S279-S293
Abstract
Complement is implicated in the pathogenesis of systemic lupus erythematosus (SLE) in several ways and may act as both friend and foe. Homozygous deficiency of any of the proteins of the classical pathway is causally associated with susceptibility to the development of SLE, especially deficiency of the earliest proteins of the activation pathway. However, complement is also implicated in the effector inflammatory phase of the autoimmune response that characterizes the disease. Complement proteins are deposited in inflamed tissues and, in experimental models, inhibition of C5 ameliorates disease in a murine model. As a further twist to the associations between the complement system and SLE, autoantibodies to some complement proteins, especially to C1q, develop as part of the autoantibody response. The presence of anti-C1q autoantibodies is associated with severe illness, including glomerulonephritis. In this chapter the role of the complement system in SLE is reviewed and hypotheses are advanced to explain the complex relationships between complement and lupus.Keywords
This publication has 187 references indexed in Scilit:
- Deposition of membrane attack complex in cutaneous lesions of lupus erythematosusJournal of the American Academy of Dermatology, 1993
- Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune depositsClinical Immunology and Immunopathology, 1991
- Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complementClinical Immunology and Immunopathology, 1991
- Autoantibody-Mediated Acquired Deficiency of C1 InhibitorNew England Journal of Medicine, 1987
- The Role of Complement and Its Receptor in the Elimination of Immune ComplexesNew England Journal of Medicine, 1986
- Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosusClinical Immunology and Immunopathology, 1986
- Radioimmunoassay of the Attack Complex of Complement in Serum from Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Mode of Inheritance of Decreased C3b Receptors on Erythrocytes of Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1982
- Cutaneous Localization of the Membrane Attack Complex in Discoid and Systemic Lupus ErythematosusNew England Journal of Medicine, 1982
- Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 levelClinical Immunology and Immunopathology, 1973